About Avantogen
Avantogen Ltd is developing and commercializing drugs and nutraceuticals in the fast growing oncology and vaccine markets. Following a company restructure in mid-2007, the company has announced a number of high-value commercial licensing revenue partnerships with leading US biotechnology players, and seen strong success with its pipeline of promising proprietary products.
The company successfully commenced re-trading on 3 October 2007, and is poised for a prosperous and promising future, for the benefit of current and future shareholders. The parent company, and its affiliates, has recently completed a number of positive, revenue transactions, which included collection of multi-million dollar upfront payments and execution of licensing documentation including future milestone payments and substantial future royalty streams.
- Focus : Manufacturer
- Industry : Pharma